Abstract
Infections have been the greatest challenge to the advancement of human race. With the advent of antibiotic therapy, successful treatment strategy was installed against infections. But, due to improper use and misuse of antibiotics along with the evolutionary advantage gained by microorganisms against antibiotics, resistant strains evolved that made the action of many antibiotics futile. Scientific world was after developing newer, more powerful antibiotics to counter the resistant strains, but later realised to change their strategy to adopt methods with the same set of antibiotic armamentaria used in a different way to overcome the resistance barrier created by the microbes. For implementing this strategy, nanoscience and technology came handy. This chapter describes the historical developments in the field of nanoscience briefly, the conventional management strategies for infections and the use of nanotechnology in the control of infections. A section on the use of nanotechnology in the control of other diseases is also added.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdul Razzak R, Florence GJ, Gunn-Moore FJ (2019) Approaches to CNS drug delivery with a focus on transporter-mediated transcytosis. Int J Mol Sci 20(12):3108
Abee T, Rombouts FM, Hugenholtz J, Guihard G, Letellier L (1994) Mode of action of nisin Z against Listeria monocytogenes Scott A grown at high and low temperatures. Appl Environ Microbiol 60(6):1962–1968
Albani D, Gloria A, Giordano C, Rodilossi S, Russo T, D’Amora U, Tunesi M, Cigada A, Ambrosio L, Forloni G (2013) Hydrogel-based nanocomposites and mesenchymal stem cells: a promising synergistic strategy for neurodegenerative disorders therapy. Sci World J. https://doi.org/10.1155/2013/270260
Alekshun MN, Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6):1037–1050
Amaral L, Kristiansen JE (2000) Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies. Int J Antimicrob Agents 14(3):173–176
Andriashvili IA, Kvachadze LI, Bashakidze RP, Adamiia R, Chanishvili TG (1986) Molecular mechanism of phage DNA protection from the restriction endonucleases of Staphylococcus aureus cells. Mol Gen Mikrobiol Virusol (8):43
Attivi D, Wehrle P, Ubrich N, Damge C, Hoffman M, Maincent P (2005) Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm 31(2):179–189
Aziz N, Fatma T, Varma A, Prasad R (2014) Biogenic synthesis of silver nanoparticles using Scenedesmus abundans and evaluation of their antibacterial activity. Journal of Nanoparticles, Article ID 689419. http://dx.doi.org/10.1155/2014/689419
Aziz N, Faraz M, Pandey R, Sakir M, Fatma T, Varma A, Barman I, Prasad R (2015) Facile algae-derived route to biogenic silver nanoparticles: Synthesis, antibacterial and photocatalytic properties. Langmuir 31:11605−11612. https://doi.org/10.1021/acs.langmuir.5b03081
Aziz N, Pandey R, Barman I, Prasad R (2016) Leveraging the attributes of Mucor hiemalis-derived silver nanoparticles for a synergistic broad-spectrum antimicrobial platform. Front Microbiol 7:1984. https://doi.org/10.3389/fmicb.2016.01984
Aziz N, Faraz M, Sherwani MA, Fatma T, Prasad R (2019) Illuminating the anticancerous efficacy of a new fungal chassis for silver nanoparticle synthesis. Front Chem 7:65. https://doi.org/10.3389/fchem.2019.00065
Bal SM, Slütter B, van Riet E, Kruithof AC, Ding Z, Kersten GF, Jiskoot W, Bouwstra JA (2010) Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations. J Control Release 142(3):374–383
Banerjee M, Mallick S, Paul A, Chattopadhyay A, Ghosh SS (2010) Heightened reactive oxygen species generation in the antimicrobial activity of a three component iodinated chitosan− silver nanoparticle composite. Langmuir 26(8):5901–5908
Barbara R, Belletti D, Pederzoli F, Masoni M, Keller J, Ballestrazzi A, Vandelli MA, Tosi G, Grabrucker AM (2017) Novel Curcumin loaded nanoparticles engineered for Blood-Brain barrier crossing and able to disrupt Abeta aggregates. Int J Pharm 526(1-2):413–424
Barber DJ, Freestone IC (1990) An investigation of the origin of the colour of the Lycurgus cup by analytical transmission electron microscopy. Archaeometry 32(1):33–45
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315(5819):1709–1712
Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F (2020) The history of nanoscience and nanotechnology: from chemical–physical applications to nanomedicine. Molecules 25(1):112
Benton B, Breukink E, Visscher I, Debabov D, Lunde C, Janc J, Mammen M, Humphrey P (2007) Telavancin inhibits peptidoglycan biosynthesis through preferential targeting of transglycosylation: evidence for a multivalent interaction between telavancin and lipid II. Int J Antimicrob Agents 29:S51–S52
Bhuyan T, Mishra K, Khanuja M, Prasad R, Varma A (2015) Biosynthesis of zinc oxide nanoparticles from Azadirachta indica for antibacterial and photocatalytic applications. Mater Sci Semicond Process 32:55–61
Bisht G, Rayamajhi S (2016) ZnO nanoparticles: a promising anticancer agent. Nano 3(Godište 2016):3–9
Biswas A, Bayer IS, Biris AS, Wang T, Dervishi E, Faupel F (2012) Advances in top–down and bottom–up surface nanofabrication: techniques, applications & future prospects. Adv Colloid Interf Sci 170(1-2):2–7
Blecher K, Nasir A, Friedman A (2011) The growing role of nanotechnology in combating infectious disease. Virulence 2(5):395–401
Bozdogan B, Appelbaum PC (2004) Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 23(2):113–119
Bracci L, Falciani C, Lelli B, Lozzi L, Runci Y, Pini A, De Montis MG, Tagliamonte A, Neri P (2003) Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem 278(47):46590–46595
Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, Van Der Oost J (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321(5891):960–964
Brunner C, Seiderer J, Schlamp A, Bidlingmaier M, Eigler A, Haimerl W, Lehr HA, Krieg AM, Hartmann G, Endres S (2000) Enhanced dendritic cell maturation by TNF-α or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol 165(11):6278–6286
Burbulys D, Trach KA, Hoch JA (1991) Initiation of sporulation in B. subtilis is controlled by a multicomponent phosphorelay. Cell 64(3):545–552
Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C (2019) Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater 10(1):4
Cederlund H, Mårdh PA (1993) Antibacterial activities of non-antibiotic drugs. J Antimicrob Chemother 32(3):355–365
Chadwick S, Kriegel C, Amiji M (2010) Nanotechnology solutions for mucosal immunization. Adv Drug Deliv Rev 62(4-5):394–407
Cheever MA, Allison JP, Ferris AS et al. (2009). The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clinical cancer research 15(17):5323–5337.
Cioffi N, Torsi L, Ditaranto N, Tantillo G, Ghibelli L, Sabbatini L, Bleve-Zacheo T, D'Alessio M, Zambonin PG, Traversa E (2005) Copper nanoparticle/polymer composites with antifungal and bacteriostatic properties. Chem Mater 17(21):5255–5262
Cleveland J, Montville TJ, Nes IF, Chikindas ML (2001) Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol 71(1):1–20
Cobley CM, Au L, Chen J, Xia Y (2010) Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery. Expert Opin Drug Deliv 7(5):577–587
Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nature Reviews Microbiology 3(10):777–788.
Cotter PD, Ross RP, Hill C (2013) Bacteriocins—a viable alternative to antibiotics? Nat Rev Microbiol 11(2):95–105
Czajkowski R, Jafra S (2009) Quenching of acyl-homoserine lactone-dependent quorum sensing by enzymatic disruption of signal molecules. Acta Biochim Pol 56(1)
Diwan M, Elamanchili P, Lane H, Gainer A, Samuel J (2003) Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses. J Drug Target 11(8–10):495–507
Dobson AP, Carper ER (1996) Infectious diseases and human population history. Bioscience 46(2):115–126
Drexler EK (1981) Molecular engineering: an approach to the development of general capabilities for molecular manipulation. Proc Natl Acad Sci U S A 78:5275–5278
Drexler EK, Peterson C, Pergamit G (1991) Unbounding the future: the nanotechnology revolution. William Morrow and Company, Inc., New York, NY
Džidić S, Šušković J, Kos B (2008) Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects. Food Technol Biotechnol 46(1)
Elsner J (2013) The Lycurgus cup. New light on old glass: recent research on byzantine mosaics and glass. The British Museum, London, UK, pp 103–111
Englander L, Friedman A (2010) Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection. J Clin Aesthet Dermatol 3(6):45
Fattal E, Rojas J, Youssef M, Couvreur P, Andremont A (1991) Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrob Agents Chemother 35(4):770–772
Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52(4):662–668
Florindo HF, Pandit S, Lacerda L, Gonçalves LM, Alpar HO, Almeida AJ (2009) The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-ɛ-caprolactone-based nanoparticles. Biomaterials 30(5):879–891
Forouhi NG, Wareham NJ (2010) Epidemiology of diabetes. Medicine 38(11):602–606
Garneau S, Martin NI, Vederas JC (2002) Two-peptide bacteriocins produced by lactic acid bacteria. Biochimie 84(5–6):577–592
Greish K (2010) Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. In: Cancer Nanotechnol. Humana Press, pp 25–37
Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E (2006) Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368(9538):874–885
Guo C, Manjili MH, Subjeck JR, Sarkar D, Fisher PB, Wang XY (2013) Therapeutic cancer vaccines: past, present, and future. In: Advances in cancer research, vol 119. Academic Press, pp 421–475
Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, Wells L, Terns RM, Terns MP (2009) RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139(5):945–956
Hauser AR (2015) Cell envelope. In: Antibiotic basic for clinicians, 2nd edn. Wolters Kluwer (India) Pvt. Ltd., New Delhi, pp 3–5
Heinrich MA, Martina B, Prakash J (2020) Nanomedicine strategies to target coronavirus. Nano Today:100961
Hearnden C, Lavelle EC (2013) Adjuvant strategies for vaccines: the use of adjuvants within the cancer vaccine setting. In: Prendergast GC,Jaffee EM (eds) Cancer immunotherapy: immune suppression and tumor growth, 2nd edn. Elsevier, New York, 655
Helgeby A, Robson NC, Donachie AM, Beackock-Sharp H, Lövgren K, Schön K, Mowat A, Lycke NY (2006) The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells. J Immunol 176(6):3697–3706
Higgins PG, Fluit AC, Schmitz FJ (2003) Fluoroquinolones: structure and target sites. Curr Drug Targets 4(2):181–190
Hoang TT, Schweizer HP (1999) Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol 181(17):5489–5497
Huang MH, Lin SC, Hsiao CH, Chao HJ, Yang HR, Liao CC, Chuang PW, Wu HP, Huang CY, Leng CH, Liu SJ (2010) Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice. PLoS One 5(8):e12279
Islan GA, Durán M, Cacicedo ML, Nakazato G, Kobayashi RK, Martinez DS, Castro GR, Durán N (2017) Nanopharmaceuticals as a solution to neglected diseases: is it possible? Acta Trop 170:16–42
Jasim A, Abdelghany S, Greish K (2017) Current update on the role of enhanced permeability and retention effect in cancer nanomedicine. In Nanotechnology-based approaches for targeting and delivery of drugs and genes. Academic Press, 62–109.
Jiang T, Mo R, Bellotti A, Zhou J, Gu Z (2014) Gel–liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy. Adv Funct Mater 24(16):2295–2304
Jin T, Sun D, Su JY, Zhang H, Sue HJ (2009) Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella enteritidis, and Escherichia coli O157: H7. J Food Sci 74(1):M46–M52
Johnston NJ, Mukhtar TA, Wright GD (2002) Streptogramin antibiotics: mode of action and resistance. Curr Drug Targets 3(4):335–344
Jones GR (1996) Successful cancer therapy with promethazine: the rationale. Med Hypotheses 46(1):25–29
Kahne D, Leimkuhler C, Lu W, Walsh C (2005) Glycopeptide and lipoglycopeptide antibiotics. Chem Rev 105(2):425–448
Kapoor G, Saigal S, Elongavan A (2017) Action and resistance mechanisms of antibiotics: a guide for clinicians. J Anaesthesiol Clin Pharmacol 33(3):300
Khan F, Khattak NS, Khan US, Rahman A (2011) Historical development of magnetite nanoparticles synthesis. J Chem Soc Pak 33(6):793
Kim BY, Rutka JT, Chan WC (2010) Nanomedicine. N Engl J Med 363(25):2434–2443
Kim SH, Kwak SY, Sohn BH, Park TH (2003) Design of TiO2 nanoparticle self-assembled aromatic polyamide thin-film-composite (TFC) membrane as an approach to solve biofouling problem. J Membr Sci 211(1):157–165
Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12(1–3):39–85
Korani M, Rezayat SM, Gilani K, Bidgoli SA, Adeli S (2011) Acute and subchronic dermal toxicity of nanosilver in guinea pig. Int J Nanomedicine 6:855
Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57(10):1486–1513
Kumar Khanna V (2012) Targeted delivery of nanomedicines. ISRN Pharmacol 2012
Kumar V, Bayda S, Hadla M, Caligiuri I, Russo Spena C, Palazzolo S, Kempter S, Corona G, Tooli G, Rizzolio F (2016a) Enhanced chemotherapeutic behavior of open-caged DNA@doxorubicin nanostructures for cancer cells. J Cell Physiol 231:106–110
Kumar V, Palazzolo S, Bayda S, Corona G, Tooli G, Rizzolio F (2016b) DNA nanotechnology for cancer therapy. Theranostics 6:710–725
Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11(1):69–86
Lambert PA (2005) Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev 57(10):1471–1485
Leach KL, Swaney SM, Colca JR, McDonald WG, Blinn JR, Thomasco LM, Gadwood RC, Shinabarger D, Xiong L, Mankin AS (2007) The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 26(3):393–402
Lellouche J, Kahana E, Elias S, Gedanken A, Banin E (2009) Antibiofilm activity of nanosized magnesium fluoride. Biomaterials 30(30):5969–5978
Lin ST, Franklin MT, Klabunde KJ (1986) Nonaqueous colloidal gold. Clustering of metal atoms in organic media. 12. Langmuir 2(2):259–260
Lind K, Kristiansen JE (2000) Effect of some psychotropic drugs and a barbiturate on mycoplasmas. Int J Antimicrob Agents 14(3):235–238
Liu L, Liu Z, Chen H, Liu H, Gao Q, Cong F, Gao G, Chen Y (2020) Subunit nanovaccine with potent cellular and mucosal immunity for COVID-19. ACS Appl Biol Mater
Liu YJ, He LL, Mustapha A, Li H, Hu ZQ, Lin MS (2009) Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157: H7. J Appl Microbiol 107(4):1193–1201
Lorch A (1999) Bacteriophages: an alternative to antibiotics. Biotechnol Dev Monit 39:14–17
Logothetidis S (2006) Nanotechnology in medicine: The medicine of tomorrow and nanomedicine. Hippokratia 10:7–21
Luby Š, Lubyová M, Šiffalovič P, Jergel M, Majková E (2015) A brief history of nanoscience and foresight in nanotechnology. In: Nanomaterials and nanoarchitectures. Springer, Dordrecht, pp 63–86
Luo S, Ma C, Zhu MQ, Ju WN, Yang Y, Wang X (2020) Application of Iron oxide nanoparticles in the diagnosis and treatment of neurodegenerative diseases with emphasis on Alzheimer’s disease. Front Cell Neurosci 14
Ma Y, Zhou T, Zhao C (2008) Preparation of chitosan–nylon-6 blended membranes containing silver ions as antibacterial materials. Carbohydr Res 343(2):230–237
MacDougall C (2017) Penicillins, cephalosporins, and other β-lactam antibiotics. In: Brunton LL, Hilal-Dandan R, Knollmann BC (eds) Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 13th edn. McGraw-Hill Education, New York, 1023–1038.
Madou MJ (2011) Manufacturing techniques for microfabrication and nanotechnology. CRC press
Martinez LR, Han G, Chacko M, Mihu MR, Jacobson M, Gialanella P, Friedman AJ, Nosanchuk JD, Friedman JM (2009) Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Investig Dermatol 129(10):2463–2469
Martinez-Gutierrez F, Olive PL, Banuelos A, Orrantia E, Nino N, Sanchez EM, Ruiz F, Bach H, Av-Gay Y (2010) Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine 6(5):681–688
Massich MD, Giljohann DA, Seferos DS, Ludlow LE, Horvath CM, Mirkin CA (2009) Regulating immune response using polyvalent nucleic acid− gold nanoparticle conjugates. Mol Pharm 6(6):1934–1940
Maurice F, Broutin I, Podglajen I, Benas P, Collatz E, Dardel F (2008) Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance. EMBO Rep 9(4):344–349
McGinn RE (2012) What’s Different, Ethically, About Nanotechnology? Foundational Questions and Answers. In A. S. Khan (Ed.), Nanotechnology: ethical and Social Implications. CRC Press, Boca Raton, Florida, pp. 67–89
McShan D, Ray PC, Yu H (2014) Molecular toxicity mechanism of nanosilver. J Food Drug Anal 22(1):116–127
Morishita M, Morishita I, Takayama K, Machida Y, Nagai T (1992) Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int J Pharm 78(1–3):1–7
Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16(10):2346
Mukherjee S, Madamsetty VS, Bhattacharya D, Roy Chowdhury S, Paul MK, Mukherjee A (2020) Recent advancements of nanomedicine in neurodegenerative disorders theranostics. Adv Funct Mater 2003054
Muttil P, Prego C, Garcia-Contreras L, Pulliam B, Fallon JK, Wang C, Hickey AJ, Edwards D (2010) Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary route. AAPS J 12(3):330–337
Nandy SK, Bapat PM, Venkatesh KV (2007) Sporulating bacteria prefers predation to cannibalism in mixed cultures. FEBS Lett 581(1):151–156
Nigam A, Gupta D, Sharma A (2014) Treatment of infectious disease: beyond antibiotics. Microbiol Res 169(9-10):643–651
Nikaido H, Zgurskaya HI (1999) Antibiotic efflux mechanisms. Curr Opin Infect Dis 12(6):529–536
Nikaido H (1994) Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264(5157):382–388
Niu X, Chen J, Gao J (2019) Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: focus on recent advances. Asian J Pharm Sci 14(5):480–496
O’sullivan L, Ross RP, Hill C (2002) Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality. Biochimie 84(5–6):593–604
O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL (2004) Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209(2):171–176
Padovani S, Sada C, Mazzoldi P, Brunetti B, Borgia I, Sgamellotti A, Giulivi A, d’Acapito F, Battaglin G (2003) Copper in glazes of renaissance luster pottery: nanoparticles, ions, and local environment. J Appl Phys 93(12):10058–10063
Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73(6):1712–1720
Palazzolo S, Hadla M, Spena CR, Bayda S, Kumar V, Lo Re F, Adeel M, Caligiuri I, Romano F, Corona G et al (2019a) Proof-of-concept multistage biomimetic liposomal DNA origami nanosystem for the remote loading of doxorubicin. ACS Med Chem Lett 10:517–521
Palazzolo S, Hadla M, Russo Spena C, Caligiuri I, Rotondo R, Adeel M, Kumar V, Corona G, Canzonieri V, Tooli G et al (2019b) An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy. Cancers 11:1997
Pardridge WM (2003) Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv 3(2):90
Perica K, Varela JC, Oelke M, Schneck J (2015) Adoptive T cell immunotherapy for cancer. Rambam Maimonides Med J 6(1):e0004
Pinto-Alphandary H, Andremont A, Couvreur P (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents 13(3):155–168
Plummer EM, Manchester M (2011) Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:174–196
Prasad R (2014) Synthesis of silver nanoparticles in photosynthetic plants. Journal of Nanoparticles, Article ID 963961, 2014, http://dx.doi.org/10.1155/2014/963961
Prasad R, Pandey R, Varma A, Barman I (2017) Polymer based nanoparticles for drug delivery systems and cancer therapeutics. In: Natural Polymers for Drug Delivery (eds. Kharkwal H and Janaswamy S), CAB International, UK 53–70
Prasad R, Swamy VS (2013) Antibacterial activity of silver nanoparticles synthesized by bark extract of Syzygium cumini. Journal of Nanoparticles 2013, http://dx.doi.org/10.1155/2013/431218
Qi L, Xu Z, Jiang X, Hu C, Zou X (2004) Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 339(16):2693–2700
Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27(1):76–83
Rai VK, Mishra N, Agrawal AK, Jain S, Yadav NP (2016) Novel drug delivery system: an immense hope for diabetics. Drug Deliv 23(7):2371–2390
Rakotoarisoa M, Angelova A (2018) Amphiphilic nanocarrier systems for curcumin delivery in neurodegenerative disorders. Medicines 5(4):126
Ranade AV, Acharya R (2015) Arka and its pharmaceutical attributes in Indian alchemy (Rasashastra): a comprehensive review. Int J Ayurvedic Med 6(4):280–288
Ren G, Hu D, Cheng EW, Vargas-Reus MA, Reip P, Allaker RP (2009) Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents 33(6):587–590
Reynolds PE (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8(11):943–950
Richard F (1960) There’s plenty of space at the bottom. Caltech Eng Sci 23(5):22–36
Rothemund PWK (2006) Folding DNA to create nanoscale shapes and patterns. Nature 440:297–302
Roco MC (2007). National nanotechnology initiative-past, present, future. In Goddard III WA, Brenner D, Lyshevski SE and Iafrate GJ (eds) Handbook on nanoscience, engineering and technology, 2nd ed, CRC Press, Boca Raton, Florida, pp. 3.1–3.26.
Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443(7113):780–786
Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S (2008) Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4(3):707–716
Mobashery S, Azucena EF (1999) Bacterial antibiotic resistance. In: Encyclopedia of life sciences. Nature Publishing Group, London, UK
Sablon E, Contreras B, Vandamme E (2000) Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis. In: New products and new areas of bioprocess engineering. Springer, Berlin, Heidelberg, pp 21–60
Saglam N, Korkusuz, F, Prasad R (2021) Nanotechnology Applications in Health and Environmental Sciences. Springer International Publishing (ISBN: 978-3-030-64410-9) https://www.springer.com/gp/book/9783030644093
Sanpui P, Murugadoss A, Prasad PD, Ghosh SS, Chattopadhyay A (2008) The antibacterial properties of a novel chitosan–Ag-nanoparticle composite. Int J Food Microbiol 124(2):142–146
Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D (2007) Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 24(12):2198–2206
Sciau P (2012) Nanoparticles in ancient materials: the metallic lustre decorations of medieval ceramics. INTECH Open Access Publisher
Scott AM, Allison JP, Wolchok JD (2012) Monoclonal antibodies in cancer therapy. Cancer Immun Arch 12(1)
Sebastian R (2017) Nanomedicine-the future of cancer treatment: a review. J Cancer Prev Curr Res 8(1):00–265
Šebestík J, Reiniš M, Ježek J (2012) Dendrimers in Neurodegenerative Diseases. In: Biomedical applications of peptide-, glyco-and glycopeptide dendrimers, and analogous dendrimeric structures. Springer, Vienna, pp 209–221
Seeman NC (1982) Nucleic acid junctions and lattices. J Theor Biol 99:237–247
Shah J, Park S, Aglyamov SR, Larson T, Ma L, Sokolov KV, Johnston KP, Milner TE, Emelianov SY (2008) Photoacoustic imaging and temperature measurement for photothermal cancer therapy. J Biomed Opt 13(3):034024
Sharma N, Sharma M, Sajid Jamal QM, Kamal MA, Akhtar S (2019) Nanoinformatics and biomolecular nanomodeling: a novel move en route for e_ective cancer treatment. Environ Sci Pollut Res Int:1–15
Si PZ, Zhang ZD, Geng DY, You CY, Zhao XG, Zhang WS (2003) Synthesis and characteristics of carbon-coated iron and nickel nanocapsules produced by arc discharge in ethanol vapor. Carbon 41(2):247–251
Singh B (2020) Biomimetic nanovaccines for COVID-19. Appl Sci Technol Ann 1(1):176–182
Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275(1):177–182
Song HY, Ko KK, Oh LH, Lee BT (2006) Fabrication of silver nanoparticles and their antimicrobial mechanisms. Eur Cells Mater 11(Suppl 1):58
Stevens KA, Sheldon BW, Klapes NA, Klaenhammer TR (1991) Nisin treatment for inactivation of Salmonella species and other gram-negative bacteria. Appl Environ Microbiol 57(12):3613–3615
Strateva T, Yordanov D (2009) Pseudomonas aeruginosa–a phenomenon of bacterial resistance. J Med Microbiol 58(9):1133–1148
Straus SK, Hancock RE (2006) Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim Biophys Acta (BBA) 1758(9):1215–1223
Subramani K, Pathak S, Hosseinkhani H (2012) Recent trends in diabetes treatment using nanotechnology. Dig J Nanomater Bios 7(1)
Sulakvelidze A, Alavidze Z, Morris JG (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45(3):649–659
Sun HX, Xie Y, Ye YP (2009) ISCOMs and ISCOMATRIX™. Vaccine 27(33):4388–4401
Swamy VS, Prasad R (2012) Green synthesis of silver nanoparticles from the leaf extract of Santalum album and its antimicrobial activity. J Optoelectronic and Biomedical Materials 4(3):53–59
Tam JP, Lu YA, Yang JL (2002) Antimicrobial dendrimeric peptides. Eur J Biochem 269(3):923–932
Taniguchi N (1974) On the basic concept of “nano-technology”. In: Proceedings of international conference on production engineering. Part II, Japan Society of Precision Engineering, Tokyo
Tenover FC (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Med 119(6):S3–10
Tolmasky ME (2000) Bacterial resistance to aminoglycosides and beta-lactams: the Tn1331 transposon paradigm. RNA 5(10):11
Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards DA (2002) Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci 99(19):12001–12005
Vannuffel P, Cocito C (1996) Mechanism of action of streptogramins and macrolides. Drugs 51(1):20–30
Strohl WR (1997) Biotechnology of antibiotics. Marcel Dekker Inc., New York, NY
Webber MA, Piddock LJ (2003) The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51(1):9–11
Williams JD (1995) Selective toxicity and concordant pharmacodynamics of antibiotics and other drugs. J Antimicrob Chemother 35(6):721–737
Wise R (1999) A review of the mechanisms of action and resistance of antimicrobial agents. Can Respir J 6:20A-A
Yadav L, Tripathi RM, Prasad R, Pudake RN, Mittal J (2017) Antibacterial activity of Cu nanoparticles against E. coli, Staphylococcus aureus and Pseudomonas aeruginosa. Nano Biomed Eng 9(1):9–14. https://doi.org/10.5101/nbe.v9i1.p9-14
Yavuz MS, Cheng Y, Chen J, Cobley CM, Zhang Q, Rycenga M, Xie J, Kim C, Song KH, Schwartz AG, Wang LV (2009) Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 8(12):935–939
Yih TC, Al-Fandi M (2006) Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 97(6):1184–1190
Yoneyama H, Katsumata R (2006) Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem 70(5):1060–1075
Zhang E, Xu H (2017) A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy. J Hematol Oncol 10(1):1–1
Zhang H, Chen G, Yu B, Cong H (2018) Emerging advanced nanomaterials for cancer photothermal therapy. Rev Adv Mater Sci 53(2):131–146
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bharathan, B.P., Rajagopal, R., Alfarhan, A., Arasu, M.V., Al-Dhabi, N.A. (2022). Advancement in Nanomaterial Synthesis and its Biomedical Applications. In: Krishnan, A., Ravindran, B., Balasubramanian, B., Swart, H.C., Panchu, S.J., Prasad, R. (eds) Emerging Nanomaterials for Advanced Technologies. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-80371-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-80371-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80370-4
Online ISBN: 978-3-030-80371-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)